Board-Certified Oral & Maxillofacial Surgery,
Arshi Lehal, DDS, MD
Dr. Arshi Lehal is a board-certified oral and maxillofacial surgeon and graduate of the St. John- Providence Oral and Maxillofacial Surgery Residency Program. Dr. Lehal is a graduate of the combined 6-year BS-DDS program at the University of Detroit Mercy and the School of Dentistry. He continued with his education at Wayne State University School of Medicine where he obtained his medical degree. He was extensively trained in the full scope of oral and maxillofacial surgery and he was elected Chief Resident in his final year of training by his superiors.
Dr. Lehal currently holds a staff position with the Ascension Macomb Oral & Maxillofacial Surgery Residency Program where he is involved with the education and surgical training of residents. He is a clinical assistant professor in the Department of osteopathic surgical specialties at Michigan State University College of Medicine. He holds staff hospital privileges and takes level 1 maxillofacial trauma calls at Corewell Health William Beaumont University Hospital, and Henry Ford Health.
Education
- Undergraduate Education
University of Detroit Mercy - Doctor of Dental Surgery
University of Detroit Mercy School of Dentistry - Doctor of Medicine
Wayne State University School of Medicine - Residency Training in Oral and Maxillofacial Surgery – St. John Providence Health System
- General Surgery Internship – St. John Hospital and Medical Center
Certifications
- Advanced Trauma Life Support
- Advanced Cardiac Life Support
- Pediatric Advanced Life Support
- Basic Life Support
Associations
- Diplomate, American Board of Oral & Maxillofacial Surgery
- American Medical Association
- Michigan State Medical Society
- Oakland County Medical Society
- American Academy of Oral and Maxillofacial Surgeons
- American Dental Association
- Michigan Dental Association
- Macomb County Dental Society
- Oakland County Dental Society
Publications
- Treatment of a BRAF V600E Positive Ameloblastoma in a Pediatric Patient with MEK Inhibitor Monotherapy – Steven Daws, Kongkrit Chaiyasate, Arshi Lehal, 2021 (sagepub.com)





